Effectiveness of Haemophilus influenzae type b Conjugate Vaccine on Prevention of Pneumonia and Meningitis in Bangladeshi Children: A Case-Control Study
Few Asian countries have introduced Haemophilus influenzae type b (Hib) conjugate vaccine because of its cost and uncertainty regarding disease burden. To estimate the effectiveness of Hib conjugate vaccine in preventing pneumonia and meningitis in children age <2 years, an incident case-control study was conducted in a birth cohort of about 68,000 infants in Dhaka city, Bangladesh. The study, published in the Pediatric Infectious Disease Journal, documented that significant fractions of pneumonia and meningitis in Bangladeshi children age <2 years can be prevented by the Hib conjugate vaccine. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author: Baqui AH, El Arifeen S, Saha SK, et al.
» Visit web page (English)
(Located at www.ncbi.nlm.nih.gov)
Citation: Baqui AH, El Arifeen S, Saha SK, et al. Effectiveness of Haemophilus influenzae type b Conjugate Vaccine on Prevention of Pneumonia and Meningitis in Bangladeshi Children: A Case-control Study. Pediatric Infectious Disease Journal. 2007;26(7):565-571.
Resource types: Peer-reviewed journal
Diseases/vaccines: Haemophilus influenzae type b (Hib)